Search
for
Sort by
Research 91–120 of 407
- Lareb provides update on lamotrigine-associated alopecia
- Using a capture–recapture method to assess the frequency of adverse drug reactions in a French university hospital
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Rivaroxaban-induced hair loss
- Curling of Hair in Two Female Patients Taking Alitretinoin
- Minimizing Factual Inconsistency and Hallucination in Large Language Models
- [Drug induced alopecia].
- SDRIFE Induced by Tofacitinib
- Utilização de plaquetas e de produtos derivados de plaquetas humanas em terapias avançadas
- 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review
- GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-analysis of Incidence, Risk, Subtypes, and Mechanisms
- Can we identify a post‐Serenoa syndrome (PSS)? A case series on sexual and psychiatric side effects of <i>Serenoa repens</i>
- Alopecia Associated to the Use of Disease-Modifying Therapies for Multiple Sclerosis: A Scoping Review Protocol
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- Hydrochlorothiazide/indometacin
- Drug-Induced Skin, Nail and Hair Disorders
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Veterinary Pharmacology
- Androgenic Effects on Ventricular Repolarization
- Update: baricitinib for alopecia areata
- Poster Abstracts
- Contraindicated use of 5-alpha-reductase inhibitors in women
- Physician Awareness of the Safe Use of Cyproterone Acetate in Europe: A Survey on the Effectiveness of Additional Risk Minimization Measures
- Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia
- Exploring the Potential Routine Use of Electronic Healthcare Record Data to Strengthen Early Signal Assessment in UK Medicines Regulation: Proof-of-Concept Study